Product Name | Influenza NP (147 - 155)TYQRTRALV |
Size | 1 mg |
Catalog # | AS-61037 |
US$ | $85 |
This peptide is a H-2Kd-restricted epitope from Influenza nucleoprotein (147-155). | |
Detailed Information | Material Safety Data Sheets (MSDS) |
Storage | -20°C |
References | Rotzschke O. et al. Nature 348, 252 (1990); Macken, C. et al. The value of a database in surveillance and vaccine selection. in Options for the Control of Influenza IV. A.D.M.E. Osterhaus, N. Cox & A.W. Hampson (Eds.) Amsterdam: Elsevier Sci. 103 (2001); Schwarze, J. et al. Am. J. Respir. Crit. Care Med.169, 801 (2004). |
Molecular Weight | 1107.3 |
TYQRTRALV | |
Sequence(Three-Letter Code) | H - Thr - Tyr - Gln - Arg - Thr - Arg - Ala - Leu - Val - OH |
Product Citations | Marois, I. et al. (2012). Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract. J Leukoc Biol 92, 107.Kahl, C. et al. (2010). Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28. Vaccine 28, 5691.Ruckwardt, T. et al. (2009). Regulatory T Cells Promote Early Influx of CD8+ T Cells in the Lungs of Respiratory Syncytial Virus-Infected Mice and Diminish Immunodominance Disparities. J Virol. 83, 3019. Rutigliano , J. A. and Graham, B. S.(2004). Prolonged Production of TNF-{alpha} Exacerbates Illness during Respiratory Syncytial Virus Infection. J Immunol173, 3408. |